Results 81 to 90 of about 37,892 (190)
Cutaneous Vasculitis and Recurrent Infection Caused by Deficiency in Complement Factor I
Frontiers in Immunology, 2018 Cutaneous leukocytoclastic vasculitis arises from immune complex deposition and dysregulated complement activation in small blood vessels. There are many causes, including dysregulated host response to infection, drug reactions, and various autoimmune ...
Sira Nanthapisal +9 more
doaj +1 more source
, 2022 Supplemental material, sj-pdf-1-imr-10.1177_03000605221097768 for Ceftriaxone-induced leukocytoclastic vasculitis: a case report and literature review of antibiotic-induced leukocytoclastic vasculitis by Aseel A Almasoudi, Eman S Bablghaith, Samaher I ...
Ayman M Falemban (12574114) +5 more
core +1 more source
ACR Open Rheumatology, Volume 8, Issue 7, July 2026.Objective Chronic pain, depressive and anxiety symptoms are common comorbidities among persons with rheumatic disease (RD) and contribute to increased symptom burden and reduced quality of life (QoL). Behavioral health (BH) interventions to motivate behavior change and promote self‐management can effectively address these conditions.
Shannon Teaw +11 more
wiley +1 more source
Leukocytoclastic Vasculitis [PDF]
Effective Pharmacotherapy, 2019 E.V. Dvoryankova +3 more
openaire +2 more sources
Case Reports in Transplantation, 2014 Recombinant granulocyte colony-stimulating factor (rG-CSF) is a myeloid growth factor that is widely used in haematology to recover neutropenia secondary to myelosuppressive chemotherapy.
Giovanbattista Ippoliti +4 more
doaj +1 more source
Arthritis &Rheumatology, Volume 78, Issue 7, Page 1393-1402, July 2026.Sjögren disease (SjD) is a common systemic autoimmune disorder characterized by inflammation of the exocrine glands, resulting in dryness. Patients frequently exhibit extraglandular manifestations affecting various organ systems. To date, there are no US Food and Drug Administration (FDA)‐approved disease‐modifying therapies for SjD. In this review, we
Rachael A. Gordon, Sara S. McCoy
wiley +1 more source
Ibuprofen-induced bullous leukocytoclastic vasculitis.
, 2001 A dramatic case of ibuprofen-induced bullous leukocytoclastic vasculitis (LCV) is described in a patient with a history of prior sensitization to ibuprofen, a common household nonsteroidal anti-inflammatory drug (NSAID) that has few reported adverse skin
Davidson, K A +2 more
core +1 more source
Cutaneous polyarteritis nodosa: A rare isolated cutaneous vasculitis
Indian Dermatology Online Journal, 2012 Cutaneous polyarteritis nodosa (CPAN) is a rare form of cutaneous vasculitis that involves small and medium sized arteries of the dermis and subcutaneous tissue without systemic involvement. It presents with tender subcutaneous nodules, digital gangrene,
Praveen Kumar A Subbanna +2 more
doaj +1 more source
A Case of Methimazole Induced Leukocytoclastic Vasculitis
Endocrinology Research and Practice, 2005 Antineutrophilic cytoplasmic antibody (ANCA)-associated vasculitis has been described frequently in patients treated with propylthiouracil (PTU). However, other antithyroid drugs, carbimazole and methimazole (MMI), rarely cause vasculitis.
Mustafa Kanat +2 more
doaj +2 more sources
Научно-практическая ревматология, 2010 The authors describe their case of leukocytoclastic vasculitis developing in a patient with ankylosing spondylitis after the second injection of adalimumab and give references to cases of vasculitis induced by anti-tumor necrosis factor- agents.
I A Doroshkevich +1 more
doaj +1 more source